Q1 2021 Processa Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Processa Pharmaceuticals's first-quarter 2021 earnings conference call and corporate update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to introduce Jim Stanker, Chief Financial Officer. Thank you, sir. You may begin.
Thank you, operator. With me on the call are Dr. David Young, our Chief Executive Officer; and Mike Floyd, our Chief Operating Officer. Before we begin, I'd like to remind everyone that a PowerPoint presentation will accompany Dr. Young's prepared remarks. To view the PowerPoint slides, please go to the earnings Press Release and click on the webcast link to follow along.
Now I'd like to begin the call by reading the Safe Harbor Statement. This statement is made pursuant to the Safe Harbor for forward-looking statements described in the Private Securities Litigation Reform
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |